Intra-Cellular Therapies Reports Third Quarter 2017 Financial Results and Provides Corporate Update

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/23/2026

1. SPCX
2. META
3. ABBV
4. SPY
5. FDX
6. IBM
7. MU
8. ACN
9. USO
10. NVDA

Go back to Intra-Cellular Therapies Reports Third Quarter 2017 Financial Results and Provides Corporate Update

Intra-Cellular Therapies (ITCI) Tops Q3 EPS by 9c

November 8, 2017 7:34 AM EST

Intra-Cellular Therapies (NASDAQ: ITCI) reported Q3 EPS of ($0.53), $0.09 better than the analyst estimate of ($0.62).

For earnings history and earnings-related data on Intra-Cellular Therapies (ITCI) click here.

... More